|
Correct Answer: inhibit protein syntheses.
the correct answer to the question about the category of mechanisms of action that includes the subcategories of aminoglycosides, macrolide, lincosamide, chloramphenicol, and tetracyclines is "inhibit protein synthesis."
inhibit protein synthesis is one of the five main categories of antimicrobial mechanisms of action, which focus on targeting key differences between human and bacterial cells to combat infections. this strategy is particularly effective because it exploits processes that are essential for bacterial survival but are either absent or significantly different in human cells, thereby reducing the risk of harm to the host.
the subcategories under inhibit protein synthesis each represent different classes of antibiotics that disrupt the process of protein synthesis in bacteria, but they do so in varied ways:
- **aminoglycosides** work by binding to the bacterial 30s ribosomal subunit, causing misreading of mrna which leads to abnormal protein production.
- **macrolides** target the 50s subunit of the bacterial ribosome, thereby inhibiting the translocation steps in protein elongation.
- **lincosamides** also bind to the 50s ribosomal subunit but inhibit the peptidyl transferase activity, which is crucial for protein chain elongation.
- **chloramphenicol** binds to the 50s ribosomal subunit and inhibits the peptidyl transferase activity, thereby preventing peptide bonds from being formed and halting protein synthesis.
- **tetracyclines** bind to the 30s subunit and block the attachment of trna to the mrna-ribosome complex, thereby preventing the addition of amino acids to the growing peptide chain.
each of these antibiotic classes plays a critical role in antimicrobial therapy by disrupting the essential biological process of protein synthesis in bacteria, making them unable to grow and replicate. this category of antibiotics is widely used in the treatment of various bacterial infections, and understanding their specific mechanisms allows healthcare providers to tailor treatments to the particular pathogens present, as determined by antimicrobial susceptibility testing. this testing helps in selecting the most effective antimicrobial agents for each individual case, enhancing treatment outcomes and helping manage resistance.
|
